(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Prostate Cancer

GVAX prostate cancer vacc ine is an investigational product currently in phase 3 clinical development for patients with advanced-stage, hormone-refractory prostate cancer. Patients will be enrolled in one of two treatment arms. Patients randomized to Arm 1 will receive vaccinations of GVAX every two weeks for six months. Participants must have confirmed diagnosis of or clinical history consistent with adenocarcinoma of the prostate and prostate cancer deemed to be unresponsive or refractory to hormone therapy. Research site located in Billings, Mont.

More Information

Please see http://www.centerwatch.com/patient/studies/cat36.html.

—–

Alzheimer’s Disease

This clinical research trial is actively recruiting moderate- and severe-stage Alzheimer’s patients 50 years of age and older to test the effectiveness and safety of an investigational dosing regimen of an approved medication. Patients must have a knowledgeable and reliable caregiver accompany them to student loan calculator all clinical visits. Research site located in Richmond, Va.

More Information

Please see http://www.centerwatch.com/patient/studies/cat11.html.

—–

Severe Premenstrual Symptom

If you regularly experience depression, irritability, angry outbursts, or changes in sleep or appetite before your period each month you may be dealing with severe seo tips PMS. If you are a woman between the ages of 18 and 49 experiencing severe PMS symptoms prior to menstruation you may be eligible for this clinical research study testing an investigational treatment. Research site located in Charlottesville, Va.

More Information

Please see http://www.centerwatch.com/patient/studies/cat707.html.

—–

Copyright 2005 CenterWatch. All rights reserved.